Studies have shown that high RCC1 expression correlates with poor survival outcomes in cancers such as breast and lung cancer, likely due to its role in enhancing proliferation, invasion, and apoptosis resistance [15,20]. This evidence concerns the gene RCC1 and lung carcinoma.